Three Weekly Irinotecan for Refractory/Relapsed Small Cell Lung Cancer

被引：0
|
作者：
Nutalapati, S. [1 ]
Yan, D. [1 ]
Morgan, R. [1 ]
Chauhan, A. [1 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
high-grade neuroendocrine carcinoma; Small cell lung cancer; Irinotecan;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P63.14
引用
收藏
页码：S1188 / S1188
页数：1
相关论文
共 50 条
  • [31] Topotecan every 28 days in refractory or relapsed small cell lung cancer
    Safont, M
    Berrocal, A
    Martinez, N
    Camps, C
    Blasco, A
    Garde, J
    Gavila, Q
    Juarez, A
    Iranzo, V
    Sirera, R
    LUNG CANCER, 2005, 49 : S327 - S327
  • [32] Single agent immunotherapy for relapsed or refractory small cell lung cancer (rrSCLC).
    Singh, Ankur
    Ahmed, Tamjeed
    Dothard, Andy
    Grant, Stefan C.
    Ruiz, Jimmy
    Farris, Michael
    Petty, William J.
    Lycan, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
    Takashi Hirose
    Takao Shirai
    Hiroo Ishida
    Kohichi Ando
    Tomohide Sugiyama
    Sojiro Kusumoto
    Takamichi Hosaka
    Masanao Nakashima
    Tohru Ohmori
    Mitsuru Adachi
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 267 - 274
  • [34] Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
    Park, Se Hoon
    Cho, Eun Kyung
    Kim, Yujin
    Kyung, Sun Young
    An, Chang Hyeok
    Lee, Sang Pyo
    Park, Jeong Woong
    Jeong, Sung Hwan
    Lee, Jae-Ik
    Choi, Soo Jin
    Park, Jinny
    Shin, Dong Bok
    Lee, Jae Hoon
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 1009 - 1014
  • [35] Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
    Se Hoon Park
    Eun Kyung Cho
    Yujin Kim
    Sun Young Kyung
    Chang Hyeok An
    Sang Pyo Lee
    Jeong Woong Park
    Sung Hwan Jeong
    Jae-Ik Lee
    Soo Jin Choi
    Jinny Park
    Dong Bok Shin
    Jae Hoon Lee
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1009 - 1014
  • [36] A pilot study of topotecan in patients with irinotecan-refractory small cell lung cancer
    Kim, Y. S.
    Hong, J.
    Park, S. H.
    Park, J.
    Cho, E. K.
    Shin, D. B.
    Lee, J. H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 388 - 388
  • [37] Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer
    Chen, Gigi
    Huynh, Minh
    Fehrenbacher, Lou
    West, Howard
    Lara, Primo N., Jr.
    Yavorkovsky, Leonid L.
    Russin, Michael
    Goldstein, Desiree
    Gandara, David
    Lau, Derick
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1401 - 1404
  • [38] A phase I study of weekly topotecan (T) in combination with sorafenib (S) for treatment of relapsed or refractory small cell lung cancer (SCLC).
    Leach, J. W.
    Swenson, K.
    Anderson, E.
    Menge, M. R.
    Tsai, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer A protocol of systematic review and meta-analysis
    Dang, Dong
    Jiang, Chao
    Xie, Ming-rui
    MEDICINE, 2020, 99 (25) : E20454
  • [40] A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
    S. Agelaki
    E. Kontopodis
    A. Kotsakis
    V. Chandrinos
    I. Bompolaki
    Ζ. Zafeiriou
    E. Papadimitraki
    D. Stoltidis
    K. Kalbakis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 45 - 51
12345